← Evidence map

ArticleFrontiers in pharmacology2022

CYP2D6 gene polymorphism and apatinib affect the metabolic profile of fluvoxamine.

Zhize Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

4 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36120346